Raily Aesthetic Medicine International Holdings Limited (HKG:2135)

HKG:2135 Revenue

Raily Aesthetic Medicine International Holdings had revenue of 104.81M CNY in the half year ending December 31, 2025, with 14.17% growth. This brings the company's revenue in the last twelve months to 219.59M, up 31.91% year-over-year. In the year 2025, Raily Aesthetic Medicine International Holdings had annual revenue of 189.41M, down -4.98%.

• Revenue (ttm): 219.59M CNY
• Revenue Growth: +31.91%
• P/S Ratio: 0.26
• Revenue / Employee: 831.77K CNY
• Employees: 264
• Market Cap: 66.85M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	189.41M	-9.93M	-4.98%
Dec 31, 2024	199.34M	9.96M	5.26%
Dec 31, 2023	189.38M	24.86M	15.11%
Dec 31, 2022	164.52M	-23.85M	-12.66%
Dec 31, 2021	188.37M	23.82M	14.48%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 2, 2026

Data Sources Report a data error